PDF(Pubmed)
Abstract：
The purpose of this paper is to examine biopharma innovation ecosystems (IEs) through the lenses of a stakeholder model. In doing so, this work aims to answer the following research question: which stakeholders are required in an IE within biopharma industry and what are their main roles in the IE value creation. The research strategy was designed according to the grounded theory methodology. By applying this methodology, data were collected through verbatim interviews with several stakeholders. Both data collection and data analysis phases were carried out concurrently up to saturation where all data were identified and their consistency across the many forms was reached. The thesis of the paper intends to prove that biopharma IEs consist of a multilevel and longitudinal set of key stakeholders. Furthermore, by investigating the Lombardy case study, it explains the role of each stakeholder with regards to the comparative advantages required in the engagement with the IE. In addition, arising from a holistic view of the biopharma IEs, this research traces the biopharma IE dynamics through the analysis of the IE\'s driving forces. This paper represents one of the first heuristic attempts to analyze in-depth biopharma IE from a holistic perspective. The paper findings can be considered to be an impactful extension to biopharma IEs world-wide. This broader scope is well supported by expert interviews as a central part of the methodology and by the investigated scientific literature.
摘要：
本文的目的是通过利益相关者模型的视角来研究生物制药创新生态系统（IE）。在这样做的时候，这项工作旨在回答以下研究问题：生物制药行业的IE需要哪些利益相关者，以及他们在IE价值创造中的主要作用是什么。研究策略是根据扎根理论方法设计的。通过应用这种方法，数据是通过与几个利益相关者的逐字访谈收集的。数据收集和数据分析阶段都同时进行，直到确定所有数据并达到多种形式的一致性为止。本文的论文旨在证明生物制药IE由多层次和纵向的关键利益相关者组成。此外，通过调查伦巴第的案例研究，它解释了每个利益相关者在参与IE所需的比较优势方面的作用。此外,从生物制药IE的整体观点出发，本研究通过分析IE的驱动力来追溯生物制药IE的动力学。本文代表了从整体角度分析深入生物制药IE的首批启发式尝试之一。论文的发现可以被认为是对全球生物制药IE的有效扩展。作为方法论的核心部分的专家访谈以及所调查的科学文献都很好地支持了这一更广泛的范围。
